DexCom, Inc. DXCM
86.62
(0.85)
(0.97%)
as of 25 Sep
- Market cap
- $33.0B
- P/E
- 33.4×
Follow DXCM
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
DexCom, Inc. (DXCM) Gross margin
DexCom, Inc.'s gross margin over the twelve months to 30 June 2026 was 62.5%, up 2.4 percentage points from fiscal 2025 (60.1%). Over the past ten years it has ranged from 60.1% (fiscal 2025) to 69.3% (fiscal 2015) — the current reading is the lowest in ten years. That is above the Medical Devices industry median of 56.0% and above the Healthcare sector median of 53.7%.
Gross margin, annual
Annual
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 60.1% | (0.36) |
| FY2024 | 60.5% | (2.73) |
| FY2023 | 63.2% | (1.53) |
| FY2022 | 64.7% | (3.91) |
| FY2021 | 68.6% | 2.19 |
| FY2020 | 66.4% | 3.33 |
| FY2019 | 63.1% | (1.25) |
| FY2018 | 64.4% | (4.13) |
| FY2017 | 68.5% | 2.49 |
| FY2016 | 66.0% | (3.25) |
Quarterly
| Period | Gross margin | Change (points) |
|---|---|---|
| Jun 2026 | 63.4% | 0.49 |
| Mar 2026 | 63.0% | 0.02 |
| Dec 2025 | 62.9% | 2.45 |
| Sep 2025 | 60.5% | 0.95 |
| 42 more quarters | Free account |
Against its own ten years
Low 60.1%
High 69.3%
Ten-year median
64.7%
Current reading's percentile
9
Gross margin against peers
| Company | Gross margin |
|---|---|
| EW Edwards Lifesciences Corporation compare | 77.8% |
| SNN Smith & Nephew SNATS, Inc. compare | 70.5% |
| BSX Boston Scientific Corporation compare | 69.9% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 69.9% |
| PEN Penumbra, Inc. compare | 67.8% |
| DXCM DexCom, Inc. | 62.5% |
| PHG Koninklijke Philips N.V. compare | 45.9% |
| STE STERIS plc compare | 44.4% |
| GEHC GE HealthCare Technologies Inc. compare | 39.5% |
| Medical Devices industry median | 56.0% |
| Healthcare sector median | 53.7% |
| Market median | 46.3% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on DXCM
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement